- Investing Ideas
- Global Pharmaceuticals & Biotech Breakout Stocks
Global Pharmaceuticals & Biotech Breakout Stocks
Results
47
Stocks where the price continues to rise after more than a year of consistent gains.
47 companies
PharmaEssentia
Market Cap: NT$621.6b
A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.
6446
NT$1,500.00
7D
21.0%
1Y
266.4%
AbCellera Biologics
Market Cap: US$3.6b
Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.
ABCL
US$11.38
7D
64.2%
1Y
147.9%
Harbin Pharmaceutical Group
Market Cap: CN¥22.4b
Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.
600664
CN¥8.91
7D
30.3%
1Y
126.1%
GemPharmatech
Market Cap: CN¥16.6b
A contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide.
688046
CN¥40.50
7D
21.6%
1Y
114.5%
Lin BioScience
Market Cap: NT$75.5b
A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.
6696
NT$912.00
7D
31.0%
1Y
466.5%
Sino BiologicalInc
Market Cap: CN¥15.8b
Engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally.
301047
CN¥130.15
7D
20.6%
1Y
76.4%
AcrobiosystemsLtd
Market Cap: CN¥15.1b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥90.21
7D
39.3%
1Y
63.4%
Marksans Pharma
Market Cap: ₹150.9b
Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.
MARKSANS
₹333.00
7D
21.6%
1Y
86.5%
HARBIN GLORIA PHARMACEUTICALS
Market Cap: CN¥10.1b
Engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally.
002437
CN¥4.53
7D
45.2%
1Y
20.5%
Replimune Group
Market Cap: US$1.4b
A clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer in the United States and the United Kingdom.
REPL
US$14.97
7D
24.1%
1Y
169.2%
Omeros
Market Cap: US$1.3b
A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.
OMER
US$17.19
7D
29.7%
1Y
289.8%
Anhui Wanbang Pharmaceutical TechnologyLtd
Market Cap: CN¥8.0b
Anhui Wanbang Pharmaceutical Technology Co.,Ltd.
301520
CN¥85.79
7D
52.3%
1Y
158.6%
Eton Pharmaceuticals
Market Cap: US$1.2b
A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.
ETON
US$58.86
7D
32.0%
1Y
245.4%
Bide Pharmatech
Market Cap: CN¥7.2b
Engages in the research, development, production, and sale of drug molecule building blocks and scientific reagents in China.
688073
CN¥83.34
7D
35.3%
1Y
38.9%
Boji Medical TechnologyLtd
Market Cap: CN¥6.6b
Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.
300404
CN¥17.34
7D
59.1%
1Y
58.8%
GlaxoSmithKlineE
Market Cap: ج.م43.5b
Engages in production of pharmaceutical chemicals.
BIOC
ج.م521.01
7D
31.0%
1Y
974.7%
Guizhou Sanli PharmaceuticalLtd
Market Cap: CN¥5.5b
Engages in the plantation, research, development, production, and sale of pharmaceutical products in China.
603439
CN¥13.53
7D
20.9%
1Y
3.7%
Aarti Pharmalabs
Market Cap: ₹77.2b
Manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally.
AARTIPHARM
₹851.20
7D
24.1%
1Y
12.4%
Xinjiang Bai Hua Cun Pharma TechLtd
Market Cap: CN¥5.3b
Engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses.
600721
CN¥13.81
7D
31.0%
1Y
73.1%
Faeth Therapeutics
Market Cap: US$737.7m
A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.
FTH
US$32.34
7D
32.6%
1Y
272.6%
Novoprotein Scientific
Market Cap: CN¥4.8b
Researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania.
688137
CN¥69.58
7D
48.9%
1Y
51.4%
Assembly Biosciences
Market Cap: US$609.8m
A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.
ASMB
US$32.95
7D
23.5%
1Y
29.5%
Shanghai Kai Kai Industry
Market Cap: CN¥3.5b
Engages in the wholesale and retail of pharmaceutical products in China.
600272
CN¥17.60
7D
35.7%
1Y
29.0%
OmniAb
Market Cap: US$497.2m
A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.
OABI
US$3.43
7D
53.1%
1Y
71.5%
EI- Nile for Pharmaceuticals and Chemical Industries
Market Cap: ج.م20.5b
Develops, produces, and sells pharmaceutical products in Egypt.
NIPH
ج.م410.02
7D
32.3%
1Y
789.4%
Kwality Pharmaceuticals
Market Cap: ₹35.7b
Together with its subsidiary, manufactures finished pharmaceutical formulations in India and internationally.
539997
₹3,444.75
7D
32.0%
1Y
222.2%
Ind-Swift Laboratories
Market Cap: ₹26.5b
Develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally.
INDSWFTLAB
₹304.18
7D
33.2%
1Y
199.9%
Fredun Pharmaceuticals
Market Cap: ₹25.6b
Manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, animal healthcare products, cosmeceuticals, mobility and rehabilitation products, and other healthcare products in India, Africa, Southeast Asia, Commonwealth of Independent States countries, MENA region, and Latin America.
539730
₹1,547.75
7D
24.4%
1Y
343.4%
Cardiol Therapeutics
Market Cap: CA$279.0m
A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$2.51
7D
26.1%
1Y
37.2%
Memphis Pharmaceuticals & Chemical Industries
Market Cap: ج.م8.7b
Engages in the research, development, manufacture, marketing, and distribution of pharmaceutical products for human and veterinary use in Egypt and internationally.
MPCI
ج.م381.00
7D
20.3%
1Y
212.1%
October PharmaE
Market Cap: ج.م7.0b
Manufactures and sells pharmaceutical products in Egypt.
OCPH
ج.م290.00
7D
21.5%
1Y
285.6%
Cue Biopharma
Market Cap: US$130.5m
A clinical-stage therapeutics company, focuses on developing various therapies for immunological disorders.
CUE
US$34.20
7D
26.1%
1Y
38.0%
RenovoRx
Market Cap: US$56.8m
A clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment.
RNXT
US$1.40
7D
25.0%
1Y
46.5%
Apollomics
Market Cap: US$38.1m
A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.
APLM
US$23.40
7D
38.5%
1Y
312.7%
Bilcare
Market Cap: ₹1.9b
Provides pharmaceutical packaging research solutions in India and internationally.
526853
₹77.12
7D
25.6%
1Y
15.3%
Pharmala Biotech Holdings
Market Cap: CA$22.4m
A biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.
MDMA
CA$0.18
7D
32.1%
1Y
37.0%